Home » Topics » Regulatory

Regulatory
RSS

Japan first country to approve omarigliptin

Sep. 28, 2015

VivaGel BV approved in E.U. for bacterial vaginosis

Sep. 25, 2015

LFB's IVIg Iqymune approved in U.K. and Denmark

Sep. 22, 2015

FDA approves Vraylar for bipolar disorder and schizophrenia

Sep. 18, 2015

Santhera receives European approval for Raxone in Leber's hereditary optic neuropathy

Sep. 10, 2015

Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure

Sep. 7, 2015

FDA approves Xuriden for hereditary orotic aciduria

Sep. 7, 2015

FDA approves Varubi for nausea and vomiting associated with cancer chemotherapy

Sep. 3, 2015

Kanuma becomes first approved treatment in E.U. for LAL-D

Sep. 1, 2015

ALK's house dust mite allergy immunotherapy approved in 11 European countries

Sep. 1, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...